745 related articles for article (PubMed ID: 14599348)
21. Enzyme fragment complementation: a flexible high throughput screening assay technology.
Eglen RM
Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):97-104. PubMed ID: 15090161
[TBL] [Abstract][Full Text] [Related]
22. Identification of iNOS inhibitors using InteraX.
Mallinder PR; Wallace AV; Allenby G
J Biomol Screen; 2009 Mar; 14(3):263-72. PubMed ID: 19211775
[TBL] [Abstract][Full Text] [Related]
23. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM
Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742
[TBL] [Abstract][Full Text] [Related]
24. Development of a simple high-throughput screening protocol based on biosynthetic activity of Mycobacterium tuberculosis glutamine synthetase for the identification of novel Inhibitors.
Singh U; Sarkar D
J Biomol Screen; 2006 Dec; 11(8):1035-42. PubMed ID: 16973920
[TBL] [Abstract][Full Text] [Related]
25. Duplexed, bead-based competitive assay for inhibitors of protein kinases.
Simons PC; Young SM; Gibaja V; Lee WC; Josiah S; Edwards BS; Sklar LA
Cytometry A; 2007 Jul; 71(7):451-9. PubMed ID: 17542028
[TBL] [Abstract][Full Text] [Related]
26. Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates.
Ward NE; O'Brian CA
Mol Pharmacol; 1992 Feb; 41(2):387-92. PubMed ID: 1538715
[TBL] [Abstract][Full Text] [Related]
27. Functional characterization of peanut serine/threonine/tyrosine protein kinase: molecular docking and inhibition kinetics with tyrosine kinase inhibitors.
Rudrabhatla P; Rajasekharan R
Biochemistry; 2004 Sep; 43(38):12123-32. PubMed ID: 15379551
[TBL] [Abstract][Full Text] [Related]
28. An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors.
Chopra P; Nanda K; Chatterjee M; Bajpai M; Dastidar SG; Ray A
Anal Biochem; 2008 Sep; 380(1):143-5. PubMed ID: 18570885
[TBL] [Abstract][Full Text] [Related]
29. A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases.
Gaudet EA; Huang KS; Zhang Y; Huang W; Mark D; Sportsman JR
J Biomol Screen; 2003 Apr; 8(2):164-75. PubMed ID: 12844437
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the InteraX system technology in a high-throughput screening environment.
Büttner FH; Kumpf R; Menzel S; Reulle D; Valler MJ
J Biomol Screen; 2005 Aug; 10(5):485-94. PubMed ID: 16093558
[TBL] [Abstract][Full Text] [Related]
31. Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform.
Trask OJ; Baker A; Williams RG; Nickischer D; Kandasamy R; Laethem C; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():419-39. PubMed ID: 17110205
[TBL] [Abstract][Full Text] [Related]
32. A novel Pim-1 kinase inhibitor targeting residues that bind the substrate peptide.
Tsuganezawa K; Watanabe H; Parker L; Yuki H; Taruya S; Nakagawa Y; Kamei D; Mori M; Ogawa N; Tomabechi Y; Handa N; Honma T; Yokoyama S; Kojima H; Okabe T; Nagano T; Tanaka A
J Mol Biol; 2012 Mar; 417(3):240-52. PubMed ID: 22306408
[TBL] [Abstract][Full Text] [Related]
33. Beta galactosidase enzyme fragment complementation as a high-throughput screening protease technology.
Naqvi T; Lim A; Rouhani R; Singh R; Eglen RM
J Biomol Screen; 2004 Aug; 9(5):398-408. PubMed ID: 15296639
[TBL] [Abstract][Full Text] [Related]
34. Novel in vitro protein fragment complementation assay applicable to high-throughput screening in a 1536-well format.
Hashimoto J; Watanabe T; Seki T; Karasawa S; Izumikawa M; Seki T; Iemura S; Natsume T; Nomura N; Goshima N; Miyawaki A; Takagi M; Shin-Ya K
J Biomol Screen; 2009 Sep; 14(8):970-9. PubMed ID: 19641222
[TBL] [Abstract][Full Text] [Related]
35. Discovery and characterization of a substrate selective p38alpha inhibitor.
Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
[TBL] [Abstract][Full Text] [Related]
36. A chemiluminescent microtiter plate assay for sensitive detection of protein kinase activity.
Lehel C; Daniel-Issakani S; Brasseur M; Strulovici B
Anal Biochem; 1997 Jan; 244(2):340-6. PubMed ID: 9025951
[TBL] [Abstract][Full Text] [Related]
37. Using IMAP technology to identify kinase inhibitors: comparison with a substrate depletion approach and analysis of the nature of false positives.
Singh P; Lillywhite B; Bannaghan C; Broad P
Comb Chem High Throughput Screen; 2005 Jun; 8(4):319-25. PubMed ID: 16101008
[TBL] [Abstract][Full Text] [Related]
38. Development of a high-throughput scintillation proximity assay for the identification of C-domain translational initiation factor 2 inhibitors.
Delle Fratte S; Piubelli C; Domenici E
J Biomol Screen; 2002 Dec; 7(6):541-6. PubMed ID: 14599352
[TBL] [Abstract][Full Text] [Related]
39. Development of a high-throughput AlphaScreen assay measuring full-length LRRK2(G2019S) kinase activity using moesin protein substrate.
Pedro L; Padrós J; Beaudet L; Schubert HD; Gillardon F; Dahan S
Anal Biochem; 2010 Sep; 404(1):45-51. PubMed ID: 20434426
[TBL] [Abstract][Full Text] [Related]
40. A fluorescence polarization competition immunoassay for tyrosine kinases.
Seethala R; Menzel R
Anal Biochem; 1998 Jan; 255(2):257-62. PubMed ID: 9451512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
